Design Therapeutics, Inc. (DSGN) Social Stream



Design Therapeutics, Inc. (DSGN): $3.69

0.08 (-2.12%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

Add DSGN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#120 of 360

in industry

DESIGN THERAPEUTICS INC (DSGN) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering DSGN.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-31 3 $42 $36 $39 $2.42 1511.57%
2022-05-02 3 $42 $30 $36 $2.42 1387.6%
2022-05-10 3 $42 $30 $34 $2.42 1304.96%
2022-05-24 4 $42 $6 $27 $2.42 1015.7%
2022-06-09 5 $42 $6 $27 $2.42 1015.7%
2022-08-09 5 $42 $6 $25.8 $2.42 966.12%
2022-11-04 5 $42 $6 $26.8 $2.42 1007.44%
2022-12-08 5 $42 $6 $24.2 $2.42 900%
2023-03-14 5 $42 $6 $22.6 $2.42 833.88%
2023-05-09 5 $42 $6 $22.8 $2.42 842.15%
2023-05-12 5 $42 $6 $22.4 $2.42 825.62%
2023-08-04 5 $42 $19 $26.5 $2.42 995.04%
2023-08-14 5 $42 $19 $26.5 $2.42 995.04%
2023-08-15 4 $42 $6 $15.25 $2.42 530.17%
2023-11-14 4 $42 $5 $15 $2.42 519.83%

The Trend in the Analyst Price Target


Over the past 27 months, DSGN's average price target has gone down $19.67.

DSGN reports an average of 304.66% for its upside potential over the past 39 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-14 5 42 6 22.60 7.070 219.66%
2023-05-10 5 42 6 22.40 6.670 235.83%
2023-08-14 5 42 19 26.50 7.330 261.53%
2023-08-15 5 42 6 15.25 2.165 604.39%
2023-11-14 4 42 5 15.00 2.290 555.02%

DSGN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 4 0 0 4

The Trend in the Broker Recommendations


Over the past 52 weeks, DSGN's average broker recommendation rating worsened by 1.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • DESIGN THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1723.86% of all US stocks.
  • DSGN has a lower variance in analysts' estimates than -1287.8% of all US stocks.
  • DESIGN THERAPEUTICS INC's number of analysts covering the stock is higher than 336.67% of Healthcare stocks.
  • In terms of how DESIGN THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is higher than 1113.52% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to DESIGN THERAPEUTICS INC are RAIN, HOWL, and VERA.

Is DSGN a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!